You searched for: fotokoagulazzjoni (Maltesiska - Engelska)

lucentis u fotokoagulazzjoni bil-lejżer f’dme jew edima makulari sekondarja għal brvo
lucentis and laser photocoagulation in dme and in macular oedema secondary to brvo

hemm ftit tal-esperjenza dwar l-għoti ta’ lucentis flimkien ma' fotokoagulazzjoni bil-lejżer.
there is some experience of lucentis administered concomitantly with laser photocoagulation.

meta jingħataw fl-istess ġurnata, lucentis għandu jingħata għall-anqas 30 minuta wara l-fotokoagulazzjoni bil-lejżer.
when given on the same day, lucentis should be administered at least 30 minutes after laser photocoagulation.

il-kawtela speċjali trid tiġi eżerċitata, u ta’ min jirrikkmanda l-itensifikar fl-immoniterjar tal-livell tal- glucose fid-demm, f’dawk il-pazjenti meta l-ġrajjiet ipogliċemiċi jkunu ta’ rilevanza klinika speċjali, bħal dawk il-pazjenti bi djuq sinifikanti ta’ l-arterji koronarji jew ta’ l-arterji li jissupplixxu l-moħħ (riskju ta’ komplikazzjonijiet tal-qalb u tal-moħħ mill-ipogliċemija), kif ukoll il-pazjenti li jbatu minn retinopatija proliferattiva, speċjalment jekk mhux qed ikunu ittrattati bil-fotokoagulazzjoni (riskju t’għama temporanja wara l-ipoglicemija).
particular caution should be exercised, and intensified blood glucose monitoring is advisable in patients in whom hypoglycaemic episodes might be of particular clinical relevance, such as in patients with significant stenoses of the coronary arteries or of the blood vessels supplying the brain (risk of cardiac or cerebral complications of hypoglycaemia) as well as in patients with proliferative retinopathy, particularly if not treated with photocoagulation (risk of transient amaurosis following hypoglycaemia).